De-novo identification of PPARγ/RXR binding sites and direct targets during adipogenesis

PLoS ONE

Volumn 4, Issue 3, 2009, Pages

  Hamza, Mohamed Sabry ^a   Pott, Sebastian ^a,b   Vega, Vinsensius B ^a   Thomsen, Jane S ^a   Kandhadayar, Gopalan Srinivasan ^a   Ng, Patrick Wei Pern ^a   Chiu, Kuo Ping ^a   Pettersson, Sven ^a,b   Wei, Chia Lin ^a   Ruan, Yijun ^a   Liu, Edison T ^a  

^a GENOME INSTITUTE OF SINGAPORE   (Singapore)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; RETINOID X RECEPTOR; 2,4 THIAZOLIDINEDIONE DERIVATIVE; ANTIDIABETIC AGENT; INSULIN; ROSIGLITAZONE; SMALL INTERFERING RNA;

ADIPOGENESIS; ANIMAL CELL; ARTICLE; BINDING SITE; CELL DIFFERENTIATION; CELL STRAIN 3T3; CONTROLLED STUDY; DEVELOPMENTAL STAGE; FATTY ACID METABOLISM; GENE EXPRESSION PROFILING; GENE FUNCTION; GENE IDENTIFICATION; GENE INDUCTION; GENE INTERACTION; GENE MAPPING; GENE TARGETING; GENETIC CONSERVATION; LIPID METABOLISM; MOUSE; NONHUMAN; NUCLEOTIDE BINDING SITE; NUCLEOTIDE SEQUENCE; PROTEIN DNA BINDING; TRANSCRIPTION INITIATION SITE; TRANSCRIPTION REGULATION; UPREGULATION; ADIPOCYTE; ANIMAL; CYTOLOGY; GENE EXPRESSION REGULATION; GENE REGULATORY NETWORK; GENETIC TRANSCRIPTION; GENETICS; METABOLISM; MICROARRAY ANALYSIS; PHYSIOLOGY; PROTEIN MULTIMERIZATION; REPRODUCIBILITY;

3T3-L1 CELLS; ADIPOCYTES; ADIPOGENESIS; ANIMALS; BINDING SITES; CELL DIFFERENTIATION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE REGULATORY NETWORKS; HYPOGLYCEMIC AGENTS; INSULIN; MICE; MICROARRAY ANALYSIS; PPAR GAMMA; PROTEIN MULTIMERIZATION; REPRODUCIBILITY OF RESULTS; RETINOID X RECEPTORS; RNA, SMALL INTERFERING; THIAZOLIDINEDIONES; TRANSCRIPTION, GENETIC;

EID: 64249157370     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0004907     Document Type: Article

References (51)

1. Chaldakov GN, et al. (2003) Adipobiology of disease: adipokines and adipokine-targeted pharmacology. Curr Pharm Des 9(12): 1023-31.
2. Dominiczak MH (2003) Obesity, glucose intolerance and diabetes and their links to cardiovascular disease. Implications for laboratory medicine. Clin Chem Lab Med 41(9): 1266-78.
3. Fischer-Posovszky P, Wabitsch M, Hochberg Z (2007) Endocrinology of adipose tissue - an update. Horm Metab Res 39(5): 314-21.
4. Gimeno RE, Klaman LD (2005) Adipose tissue as an active endocrine organ: recent advances. Curr Opin Pharmacol 5(2): 122-8.
5. Lazar MA (2005) PPAR gamma, 10 years later. Biochimie 87(1): 9-13.
6. Lehrke M, Lazar MA (2005) The many faces of PPARgamma. Cell 123(6): 993-9.
7. Panigrahy D, et al. (2005) PPARgamma as a therapeutic target for tumor angiogenesis and metastasis. Cancer Biol Ther 4(7): 687-93.
8. Rangwala SM, Lazar MA (2004) Peroxisome proliferator-activated receptor gamma in diabetes and metabolism. Trends Pharmacol Sci 25(6): 331-6.
9. Takano H, et al. (2004) Pleiotropic actions of PPAR gamma activators thiazolidinediones in cardiovascular diseases. Curr Pharm Des 10(22): 2779-86.
10. Balakumar P, Rose M, Singh M (2007) PPAR Ligands: Are They Potential Agents for Cardiovascular Disorders? Pharmacology 80(1): 1-10.
11. Forman BM, et al. (1995) 15-Deoxy-delta 12, 14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR gamma. Cell 83(5): 803-12.
12. Gervois P, Fruchart JC, Staels B (2007) Drug Insight: mechanisms of action and therapeutic applications for agonists of peroxisome proliferator-activated receptors. Nat Clin Pract Endocrinol Metab 3(2): 145-56.
13. Heinaniemi M, et al. (2007) Meta-analysis of primary target genes of peroxisome proliferator-activated receptors. Genome Biol 8(7): R147.
14. Lemay DG, Hwang DH (2006) Genome-wide identification of peroxisome proliferator response elements using integrated computational genomics. J Lipid Res 47(7): 1583-7.
15. A IJ, et al. (1997) Polarity and specific sequence requirements of peroxisome proliferator-activated receptor (PPAR)/retinoid X receptor heterodimer binding to DNA. A functional analysis of the malic enzyme gene PPAR response element. J Biol Chem 272(32): 20108-17.
16. Juge-Aubry C, et al. (1997) DNA binding properties of peroxisome proliferatoractivated receptor subtypes on various natural peroxisome proliferator response elements. Importance of the 59-flanking region. J Biol Chem 272(40): 25252-9.
17. Euskirchen GM, et al. (2007) Mapping of transcription factor binding regions in mammalian cells by ChIP: comparison of array- and sequencing-based technologies. Genome Res 17(6): 898-909.
18. Thomas PD, et al. (2003) PANTHER: a library of protein families and subfamilies indexed by function. Genome Res 13(9): 2129-41.
19. Thomas PD, et al. (2006) Applications for protein sequence-function evolution data: mRNA/protein expression analysis and coding SNP scoring tools. Nucleic Acids Res 34(Web Server issue): W645-50.
20. Barak Y, et al. (1999) PPAR gamma is required for placental, cardiac, and adipose tissue development. Mol Cell 4(4): 585-95.
21. Wei CL, et al. (2006) A global map of p53 transcription-factor binding sites in the human genome. Cell 124(1): 207-19.
22. Ng P, et al. (2006) Multiplex sequencing of paired-end ditags (MS-PET): a strategy for the ultra-high-throughput analysis of transcriptomes and genomes. Nucleic Acids Res 34(12): e84.
23. Lin CY, et al. (2007) Whole-Genome Cartography of Estrogen Receptor alpha Binding Sites. PLoS Genet 3(6): e87.
24. Lin Z, et al. (2007) Novel estrogen receptor-alpha binding sites and estradiol target genes identified by chromatin immunoprecipitation cloning in breast cancer. Cancer Res 67(10): 5017-24.
25. Vega VB, Y.R.,Wing-KinSung (2008) A Streamlined and Generalized Analysis of Chromatin ImmunoPrecipitation Paired-End diTag Data. International Conference on Computational Science 2008. http://www.springerlink.com/ content/l36xm8252975q428/?p=c1fbf9fdc67d4ee8a10e25ca2d8a3dd1&pi=15.
26. Tontonoz P, et al. (1994) Adipocyte-specific transcription factor ARF6 is a heterodimeric complex of two nuclear hormone receptors, PPAR gamma and RXR alpha. Nucleic Acids Res 22(25): 5628-34.
27. Walczak R, Tontonoz P (2002) PPARadigms and PPARadoxes: expanding roles for PPARgamma in the control of lipid metabolism. J Lipid Res 43(2): 177-86.
28. Loh YH, et al. (2006) The Oct4 and Nanog transcription network regulates pluripotency in mouse embryonic stem cells. Nat Genet 38(4): 431-40.
29. Pavesi G, et al. (2004) Weeder Web: discovery of transcription factor binding sites in a set of sequences from co-regulated genes. Nucleic Acids Res 32(Web Server issue): W199-203.
30. Okuno M, et al. (2001) Dual DNA-binding specificity of peroxisome-proliferator-activated receptor gamma controlled by heterodimer formation with retinoid X receptor alpha. Biochem J 353(Pt 2): 193-8.
31. Palmer CN, et al. (1995) Novel sequence determinants in peroxisome proliferator signaling. J Biol Chem 270(27): 16114-21.
32. Brun RP, et al. (1996) Differential activation of adipogenesis by multiple PPAR isoforms. Genes Dev 10(8): 974-84.
33. Tontonoz P, Hu E, Spiegelman BM (1994) Stimulation of adipogenesis in fibroblasts by PPAR gamma 2, a lipid-activated transcription factor. Cell 79(7): 1147-56.
34. Tontonoz P, et al. (1997) Terminal differentiation of human liposarcoma cells induced by ligands for peroxisome proliferator-activated receptor gamma and the retinoid X receptor. Proc Natl Acad Sci U S A 94(1): 237-41.
35. Mangelsdorf DJ, Evans RM (1995) The RXR heterodimers and orphan receptors. Cell 83(6): 841-50.
36. Lim CA, et al. (2007) Genome-wide mapping of RELA(p65) binding identifies E2F1 as a transcriptional activator recruited by NF-kappaB upon TLR4 activation. Mol Cell 27(4): 622-35.
37. Mikkers H, et al. (2004) Mice deficient for all PIM kinases display reduced body size and impaired responses to hematopoietic growth factors. Mol Cell Biol 24(13): 6104-15.
38. Popivanova BK, et al. (2007) Proto-oncogene, Pim-3 with serine/threonine kinase activity, is aberrantly expressed in human colon cancer cells and can prevent Bad-mediated apoptosis. Cancer Sci 98(3): 321-8.
39. Li YY, et al. (2006) Pim-3, a proto-oncogene with serine/threonine kinase activity, is aberrantly expressed in human pancreatic cancer and phosphorylates bad to block bad-mediated apoptosis in human pancreatic cancer cell lines. Cancer Res 66(13): 6741-7.
40. Krishnan A, Nair SA, Pillai MR (2007) Biology of PPAR gamma in cancer: a critical review on existing lacunae. Curr Mol Med 7(6): 532-40.
41. Danesch U, Hoeck W, Ringold GM (1992) Cloning and transcriptional regulation of a novel adipocyte-specific gene, FSP27. CAAT-enhancer-binding protein (C/EBP) and C/EBP-like proteins interact with sequences required for differentiation-dependent expression. J Biol Chem 267(10): 7185-93.
42. Puri V, et al. (2007) Fat-specific protein 27, a novel lipid droplet protein that enhances triglyceride storage. J Biol Chem 282(47): 34213-8.
43. Keller P, et al. (2008) Fat-specific protein 27 regulates storage of triacylglycerol. J Biol Chem.
44. Hong YH, et al. (2005) Acetate and propionate short chain fatty acids stimulate adipogenesis via GPCR43. Endocrinology 146(12): 5092-9.
45. Yang RY, et al. (2004) Galectin-12 is required for adipogenic signaling and adipocyte differentiation. J Biol Chem 279(28): 29761-6.
46. Ailhaud G, Teboul M, Massiera F (2002) Angiotensinogen, adipocyte differentiation and fat mass enlargement. Curr Opin Clin Nutr Metab Care 5(4): 385-9.
47. Janke J, et al. (2002) Mature adipocytes inhibit in vitro differentiation of human preadipocytes via angiotensin type 1 receptors. Diabetes 51(6): 1699-707.
48. Sharma AM, Staels B (2007) Review: Peroxisome proliferator-activated receptor gamma and adipose tissue-understanding obesity-related changes in regulation of lipid and glucose metabolism. J Clin Endocrinol Metab 92(2): 386-95.
49. Gotoh C, et al. (2007) The regulation of adipogenesis through GPR120. Biochem Biophys Res Commun 354(2): 591-7.
50. Ko JA, et al. (2006) PDZRN3 (LNX3, SEMCAP3) is required for the differentiation of C2C12 myoblasts into myotubes. J Cell Sci 119(Pt 24): 5106-13.
51. FitzPatrick DR, Germain-Lee E, Valle D (1995) Isolation and characterization of rat and human cDNAs encoding a novel putative peroxisomal enoyl-CoA hydratase. Genomics 27(3): 457-66.